Stay updated on Empagliflozin in Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.

Latest updates to the Empagliflozin in Heart Failure Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now shows a new system revision label 'Revision: v3.5.0' and the previous 'Revision: v3.4.3' entry has been removed.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedA new site revision, v3.4.2, was added and the previous revision v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1, a minor platform update with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now displays a glossary toggle and adds a 'Last Update Submitted that Met QC Criteria' label, as well as a 'No FEAR Act Data' notice with Revision: v3.4.0. The older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 have been removed.SummaryDifference0.2%

- Check83 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no observable changes to study details or layout.SummaryDifference0.1%

Stay in the know with updates to Empagliflozin in Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin in Heart Failure Clinical Trial page.